Sharip A, Kunz J
Cells. 2025; 14(4).
PMID: 39996739
PMC: 11854242.
DOI: 10.3390/cells14040266.
Huang W, Zheng J, Wang M, Du L, Bai L, Tang H
Front Med (Lausanne). 2024; 11:1502368.
PMID: 39735699
PMC: 11681627.
DOI: 10.3389/fmed.2024.1502368.
Wei H, Ren J, Feng X, Zhao C, Zhang Y, Yuan H
Cell Prolif. 2024; 58(3):e13774.
PMID: 39566909
PMC: 11882747.
DOI: 10.1111/cpr.13774.
Yang G, Xiang J, Yang X, Liu X, Li Y, Li L
Elife. 2024; 13.
PMID: 39495216
PMC: 11534337.
DOI: 10.7554/eLife.98524.
Sun Y, Li B, Zhou X, Rao T, Cheng F
Sci Rep. 2024; 14(1):20949.
PMID: 39251681
PMC: 11383970.
DOI: 10.1038/s41598-024-71755-y.
Pirfenidone use in fibrotic diseases: What do we know so far?.
Torre A, Martinez-Sanchez F, Narvaez-Chavez S, Herrera-Islas M, Aguilar-Salinas C, Cordova-Gallardo J
Immun Inflamm Dis. 2024; 12(7):e1335.
PMID: 38967367
PMC: 11225083.
DOI: 10.1002/iid3.1335.
Exploring unconventional targets in myofibroblast transdifferentiation outside classical TGF- signaling in renal fibrosis.
Lathan R
Front Physiol. 2024; 15:1296504.
PMID: 38808357
PMC: 11130449.
DOI: 10.3389/fphys.2024.1296504.
ELABELA-derived peptide ELA13 attenuates kidney fibrosis by inhibiting the Smad and ERK signaling pathways.
Yan Z, Shi Y, Yang R, Xue J, Fu C
J Zhejiang Univ Sci B. 2024; 25(4):341-353.
PMID: 38584095
PMC: 11009446.
DOI: 10.1631/jzus.B2300033.
Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer.
Lei Y, Xu J, Xiao M, Wu D, Xu H, Yang J
Br J Cancer. 2024; 130(9):1505-1516.
PMID: 38454166
PMC: 11058874.
DOI: 10.1038/s41416-024-02631-9.
Farnesol Inhibits PI3 Kinase Signaling and Inflammatory Gene Expression in Primary Human Renal Epithelial Cells.
Muller A, Lozoya M, Chen X, Weissig V, Nourbakhsh M
Biomedicines. 2023; 11(12).
PMID: 38137543
PMC: 10741437.
DOI: 10.3390/biomedicines11123322.
The Nephroprotective Effects of the Allogeneic Transplantation with Mesenchymal Stromal Cells Were Potentiated by ω3 Stimulating Up-Regulation of the PPAR-γ.
de Oliveira A, Convento M, Razvickas C, Castino B, Leme A, da Silva Luiz R
Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895955
PMC: 10610511.
DOI: 10.3390/ph16101484.
The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease.
Gluba-Sagr A, Franczyk B, Rysz-Gorzynska M, Lawinski J, Rysz J
Biomedicines. 2023; 11(9).
PMID: 37760798
PMC: 10525803.
DOI: 10.3390/biomedicines11092358.
Nephroprotective Effects of Cardamonin on Renal Ischemia Reperfusion Injury/UUO-Induced Renal Fibrosis.
Zhang B, Chen Z, Jiang Z, Huang S, Liu X, Wang L
J Agric Food Chem. 2023; 71(36):13284-13303.
PMID: 37646396
PMC: 10510707.
DOI: 10.1021/acs.jafc.3c01880.
Evaluation of Renal Fibrosis Using Magnetization Transfer Imaging at 1.5T and 3T in a Porcine Model of Renal Artery Stenosis.
Gandhi D, Al Saeedi M, Krier J, Jiang K, Glockner J, Lerman L
J Clin Med. 2023; 12(8).
PMID: 37109291
PMC: 10140905.
DOI: 10.3390/jcm12082956.
An update on renal fibrosis: from mechanisms to therapeutic strategies with a focus on extracellular vesicles.
Wang C, Li S, Zhong X, Liu B, Lv L
Kidney Res Clin Pract. 2023; 42(2):174-187.
PMID: 37037480
PMC: 10085720.
DOI: 10.23876/j.krcp.22.159.
Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.
Denicolo S, Nair V, Leierer J, Rudnicki M, Kretzler M, Mayer G
Biomolecules. 2023; 13(1).
PMID: 36671474
PMC: 9855364.
DOI: 10.3390/biom13010089.
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis.
Park C, Yoo T
Pharmaceuticals (Basel). 2022; 15(12).
PMID: 36558936
PMC: 9783223.
DOI: 10.3390/ph15121485.
Deciphering the Antifibrotic Property of Metformin.
Septembre-Malaterre A, Boina C, Douanier A, Gasque P
Cells. 2022; 11(24).
PMID: 36552855
PMC: 9777391.
DOI: 10.3390/cells11244090.
Up-regulation of the human-specific CHRFAM7A gene protects against renal fibrosis in mice with obstructive nephropathy.
Zhou B, Zhang Y, Dang X, Li B, Wang H, Gong S
J Cell Mol Med. 2022; 27(1):52-65.
PMID: 36479618
PMC: 9806291.
DOI: 10.1111/jcmm.17630.
The Protective Effect of Zebularine, an Inhibitor of DNA Methyltransferase, on Renal Tubulointerstitial Inflammation and Fibrosis.
Koh E, Kim S, Son M, Park J, Pyo J, Kim W
Int J Mol Sci. 2022; 23(22).
PMID: 36430531
PMC: 9697081.
DOI: 10.3390/ijms232214045.